Nanomaterials, like nanoparticles, micelles, nano-sheets, nanotubes and quantum dots,
have great potentials in biomedical fields. However, their delivery is highly limited by the …

Minimal therapeutic advances have been achieved over the past two decades for
glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli …

A dual-targeting drug delivery system for paclitaxel (PTX) was developed by functionalizing
novel polyester-based nanoparticles (NPs) with peptides possessing special affinity for low …

Drug-loaded nanocarriers and nanoparticulate systems used for drug release require a
careful in vivo evaluation in terms of physicochemical and pharmacokinetic properties …

Bladder cancer is the 10th most diagnosed cancer, with almost 10 M cancer deaths last year
worldwide. Currently, chemotherapy is widely used as adjuvant therapy after surgical …

Cancer, which is a leading cause of death, contributes significantly to reducing life
expectancy worldwide. Even though paclitaxel (PTX) is known as one of the main anticancer …

Poly (lactic acid)(PLA) nanoparticles (NPs) are widely investigated due to their
bioresorbable, biocompatible and low immunogen properties. Interestingly, many recent …

Background: Polymer-based nanoparticles as drug-delivery systems offer new therapeutic
opportunities. Among them, ligand-mediated targeting, which increases selectivity and …

Cancer, which is a leading cause of death, contributes significantly to reducing life
expectancy worldwide. Even though paclitaxel (PTX) is known as one of the main anticancer …

Hoy en día, el cáncer es una de las principales causas de muerte a nivel mundial. La
urgente necesidad de contar con sistemas que permitan una terapia exitosa, ha promovido …